These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 10083982

  • 1. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
    Jajoo HK, Mamidi RN, Vakkalanka SV, Sathyavageeswaran S, Katneni K, Ayalasomayajula PS, Rao BP, Lohray BB, Subramaniam S.
    Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
    [Abstract] [Full Text] [Related]

  • 2. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR.
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [Abstract] [Full Text] [Related]

  • 3. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S.
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [Abstract] [Full Text] [Related]

  • 4. Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats.
    Mamidi RN, Katneni K, Mullangi R, Ramanujam R.
    Eur J Drug Metab Pharmacokinet; 2002 Jan; 27(3):175-8. PubMed ID: 12365198
    [Abstract] [Full Text] [Related]

  • 5. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR.
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S, Chompootaweep S, Thaworn N.
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [Abstract] [Full Text] [Related]

  • 7. High-performance liquid chromatographic determination of the insulin sensitizing agent DRF-2189 in rat plasma.
    Jajoo HK, Rao Mamidi NV, Kasiram K, Prakash AS, Swaroop Kumar VV, Bheema Rao P, Bhushan V, Subramaniam S.
    J Chromatogr B Biomed Sci Appl; 1998 Apr 10; 707(1-2):241-6. PubMed ID: 9613956
    [Abstract] [Full Text] [Related]

  • 8. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H, Brickl R, Eschey H, Greischel A, Heinzel G, König E, Limmer J, Rupprecht E.
    Arzneimittelforschung; 1997 Mar 10; 47(3):247-52. PubMed ID: 9105542
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G, Silingardi S.
    Arzneimittelforschung; 1994 Dec 10; 44(12A):1460-4. PubMed ID: 7857342
    [Abstract] [Full Text] [Related]

  • 10. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.
    Varanasi KK, Potharaju S, Rajak S, Veeraraghavan S, Mallick P, Vakkalanka SK.
    Methods Find Exp Clin Pharmacol; 2008 Sep 10; 30(7):537-42. PubMed ID: 18985182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB, Bhushan V, Rao BP, Madhavan GR, Murali N, Rao KN, Reddy AK, Rajesh BM, Reddy PG, Chakrabarti R, Vikramadithyan RK, Rajagopalan R, Mamidi RN, Jajoo HK, Subramaniam S.
    J Med Chem; 1998 May 07; 41(10):1619-30. PubMed ID: 9572887
    [Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatographic determination of oxatomide and its metabolite and its application to pharmacokinetic study in rat plasma.
    Kikuchi K, Ohishi T, Masuike T, Ohmori K, Sakai K.
    Arzneimittelforschung; 2002 May 07; 52(10):754-63. PubMed ID: 12442638
    [Abstract] [Full Text] [Related]

  • 14. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
    Heitzmann T, Neidlein R, Freund P, Reiff K, Strein K.
    Arzneimittelforschung; 1995 Dec 07; 45(12):1284-8. PubMed ID: 8595085
    [Abstract] [Full Text] [Related]

  • 15. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK, Sólyom AM, Rodriguez VP, Sipes IG.
    Toxicol Sci; 2007 Apr 07; 96(2):237-45. PubMed ID: 17234645
    [Abstract] [Full Text] [Related]

  • 16. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
    Miller AK, DiCicco RA, Freed MI.
    Clin Ther; 2002 Jul 07; 24(7):1062-71. PubMed ID: 12182252
    [Abstract] [Full Text] [Related]

  • 17. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS, Koh YY, Chung JH, Choi DH, Han HK.
    J Pharm Pharmacol; 2008 Oct 07; 60(10):1403-7. PubMed ID: 18812034
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH, Yoo SD, Kim YS, Lee KH, Lee HS.
    Biopharm Drug Dispos; 2007 Nov 07; 28(8):423-9. PubMed ID: 17828714
    [Abstract] [Full Text] [Related]

  • 19. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z, Tam YK, Diakur J, Wiebe LI.
    J Pharm Pharm Sci; 2002 Nov 07; 5(3):292-8. PubMed ID: 12553899
    [Abstract] [Full Text] [Related]

  • 20. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
    Izumi T, Enomoto S, Hosiyama K, Sasahara K, Shibukawa A, Nakagawa T, Sugiyama Y.
    J Pharmacol Exp Ther; 1996 Jun 07; 277(3):1630-41. PubMed ID: 8667232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.